National Minority Health Assn. Appoints Health Tech Executive to Board

GILBERT, Ariz. - EntSun -- The National Minority Health Association (NMHA) has announced that David Cole, has been elected to its board of directors.  This 501c3, not-for-profit organization is focused on eliminating the healthcare disparity gap experienced by minorities.

David Cole is an accomplished healthcare professional and business executive with 30+ years of experience in building multiple successful products and companies. He is an expert in healthcare program development,  sales and marketing, and complex retail channel development. A skilled strategist and business development specialist, David has extensive experience with non-profit organizations, government agencies, regulatory authorities, health care systems, and providers.

David studied physics and computer science at the University of Georgia and Georgia Institute of Technology and went on to co-found Statchek, Inc., a pioneer in electronic visit verification, which was sold to a public company in 1999 (now Wipro NYSE-WIT.) David then served as the first vice president of technology for AccentCare, Inc., a national provider of skilled services at home. He subsequently co-founded two non-medical home care agencies and served as the executive director for Interim Home Health in Atlanta, GA, a Medicare-certified home health agency. David also co-founded the former National Memory Impairment Institute, a 501C3 not for profit that developed educational programs for caregivers caring for patients with dementia and Alzheimer's disease. David was also a co-founder of MRI First, a low-cost provider of MRI imaging services, where he continues to serve as a director on its board.

More on EntSun News

• Matter Studio Gallery Presented "Evolving Matter," a Pop-Up Exhibition Examining Material Transformation and Contemporary Form
• Justin Jeansonne and his Music Manager Donna Cardellino Head To Nashville
• Raquel Riley Thomas' AOAGWLLC and Hazel Simpson's Sis to Sis Productions Ink Co-Production Deal, Launching Strategic Creative Alliance
• InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
• Bay Street Yard to host "Girls Night Out the Show" on April 20

An expert in the areas of home care services, he also developed CareMaestro, a system that reduced readmissions for a large west-coast hospital chain more than 80%. He is a certified Chronic Care Professional (CCP) from the Health Sciences Institute, a California-certified administrator for Residential Care Facilities for the Elderly (RCFE), a former Medicare administrator, and a Certified Memory Impairment Specialist-Instructor (CMIS-I), from the National Memory Impairment Institute.

"We are thrilled that David has joined our board.  His telehealth, health tech, and home health background and experience will be critical to the success in achieving our mission," said Dr. David L. Dalton, Board Chairman and CEO of Univec Conglomerate Inc.  "David is an example of our board expanding our expertise as we deliver new programs that help reduce the healthcare gap," continued Dalton.

About NMHA.  The National Minority Health Association, founded in 1988 by Dr. David L. Dalton, Chairman, and CEO of Univec Conglomerate Inc.(UNVC), achieved its initial mission of seeing Offices of Minority Health established in all 50 states.  Today the NMHA is adding to its mission and deploying new programs that utilize patient-centered, value-based care, and new ways of enhancing care to patients where they are, lowering costs, and improving outcomes for minority and underserved communities.  To help sponsor or for more information visit www.theNMHA.org

More on EntSun News

• CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
• Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
• PBR returns to Queen Creek Arizona
• Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
• Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL